Equator Therapeutics
PrivateLast Round
Grant
Sep 20, 2021
Est. Valuation
$1.79M
Total Funding Raised
$462,400
Company Overview
Equator Therapeutics is a biotechnology company developing a first-in-class drug designed to treat obesity and other metabolic disorders by stimulating mitochondrial thermogenesis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Equator Therapeutics Comparables
Compare Equator Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incipiam Pharma | 87% | |
| Adipo Therapeutics | 86% | |
| Eolo Pharma | 86% |
Equator Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 20, 2021 | ||||
| Accelerator | Mar 18, 2020 |
Key People
Founding team and executive leadership
Equator Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioGenerator Ventures | VC Round |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Y Combinator | Accelerator |
| SV Latam Capital | Accelerator |
| Healthspan Capital | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2021
$1.9M grant awarded by NIH RADx.
- Mar 18, 2020
$125K round led by Y Combinator
Equator Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Equator Therapeutics's valuation, stock price, and market status.
Is Equator Therapeutics a public or private company?
Equator Therapeutics is a private company.
What is the current stock price of Equator Therapeutics?
Equator Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Equator Therapeutics worth (valuation)?
Equator Therapeutics's valuation is estimated at $1.8M based on funding round data.
Can I buy Equator Therapeutics stock?
Equator Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Equator Therapeutics's last funding round?
Equator Therapeutics's most recent funding round was Grant on March 16, 2020.
Who are the main investors in Equator Therapeutics?
Key investors in Equator Therapeutics include Y Combinator.
Will Equator Therapeutics IPO soon?
No public IPO plans have been announced for Equator Therapeutics.
How can I track Equator Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Equator Therapeutics's secondary market activity and sign up for updates.